Small and midcap stocks rose sharply on Tuesday, lifting broader markets and outperforming benchmarks. Coforge led midcap gains, while Ola ...

Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...

Shares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its C...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Gland Pharma on Monday reported 12 per cent year-on-year increase in profit after tax (PAT) at Rs 184 crore for the September quarter, aide...

Gland Pharma Ltd on Tuesday reported a 3 per cent decline in consolidated net profit to Rs 186.54 crore in the fourth quarter ended March 3...

Gland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 cr...

Gland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to 'Reduce' with ...

The company declared its first-ever post-listing dividend of Rs 20 per equity share for FY24.

Global brokerage firm Jefferies upgraded Gland Pharma's stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1...

Gland Pharma's stock prices hit a 20% lower circuit on BSE after the firm reported a 72% YoY drop in net profit to Rs 79 crore in Q4FY23 du...

Gland Pharma's consolidated revenue from operations stood at Rs 1,044 crore as against Rs 1,080 crore in the same quarter a year ago

Gland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...

Drug firm Gland Pharma on Wednesday reported an 11.83 per cent increase in its consolidated net profit to Rs 350.7 crore for the quarter en...

Consolidated revenue from operations of the company stood at Rs 1,153.9 crore for the quarter under consideration. It was Rs 884.2 crore fo...

Vitane Biologics, with around 100 personnel, has a dedicated research and development facility and a manufacturing plant to handle both mic...

Competition Commission of India (CCI) has given nod for the proposal, which involves multiple transactions, saying the deal does not raise ...